88 related articles for article (PubMed ID: 20462689)
1. Use of potassium ferrocyanide as habit modifier in the size reduction and phase modification of ammonium nitrate crystals in slurries.
Vargeese AA; Joshi SS; Krishnamurthy VN
J Hazard Mater; 2010 Aug; 180(1-3):583-9. PubMed ID: 20462689
[TBL] [Abstract][Full Text] [Related]
2. Effect of method of crystallization on the IV-III and IV-II polymorphic transitions of ammonium nitrate.
Vargeese AA; Joshi SS; Krishnamurthy VN
J Hazard Mater; 2009 Jan; 161(1):373-9. PubMed ID: 18471968
[TBL] [Abstract][Full Text] [Related]
3. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
Attama AA; Müller-Goymann CC
Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
[TBL] [Abstract][Full Text] [Related]
4. Anatase-brookite mixed phase nano TiO2 catalyzed homolytic decomposition of ammonium nitrate.
Vargeese AA; Muralidharan K
J Hazard Mater; 2011 Sep; 192(3):1314-20. PubMed ID: 21742435
[TBL] [Abstract][Full Text] [Related]
5. Metastability and transformation of polymorphic crystals in biodegradable poly(butylene adipate).
Gan Z; Kuwabara K; Abe H; Iwata T; Doi Y
Biomacromolecules; 2004; 5(2):371-8. PubMed ID: 15002996
[TBL] [Abstract][Full Text] [Related]
6. Study of process induced polymorphic transformations in fluconazole drug.
Desai SR; Dharwadkar SR
Acta Pol Pharm; 2009; 66(2):115-22. PubMed ID: 19719043
[TBL] [Abstract][Full Text] [Related]
7. Study of polymorphic transformation of ornidazole drug by differential scanning calorimetry and other complementary techniques.
Desai SR; Dharwadkar SR
Acta Pol Pharm; 2008; 65(4):409-13. PubMed ID: 19051580
[TBL] [Abstract][Full Text] [Related]
8. Crystal modification of dipyridamole using different solvents and crystallization conditions.
Adhiyaman R; Basu SK
Int J Pharm; 2006 Sep; 321(1-2):27-34. PubMed ID: 16842943
[TBL] [Abstract][Full Text] [Related]
9. Does the solid-liquid crystal phase transition provoke the spin-state change in spin-crossover metallomesogens?
Seredyuk M; Gaspar AB; Ksenofontov V; Galyametdinov Y; Kusz J; Gütlich P
J Am Chem Soc; 2008 Jan; 130(4):1431-9. PubMed ID: 18181626
[TBL] [Abstract][Full Text] [Related]
10. Supercritical fluid crystallization of griseofulvin: crystal habit modification with a selective growth inhibitor.
Jarmer DJ; Lengsfeld CS; Anseth KS; Randolph TW
J Pharm Sci; 2005 Dec; 94(12):2688-702. PubMed ID: 16258994
[TBL] [Abstract][Full Text] [Related]
11. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM
Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297
[TBL] [Abstract][Full Text] [Related]
12. Solid dispersion of spironolactone with porous silica prepared by the solvent method.
Uchino T; Yasuno N; Yanagihara Y; Suzuki H
Pharmazie; 2007 Aug; 62(8):599-603. PubMed ID: 17867555
[TBL] [Abstract][Full Text] [Related]
13. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.
Rosenblatt KM; Bunjes H
Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318
[TBL] [Abstract][Full Text] [Related]
14. Phase transitions and structures of novel pyrenes potentially useful in photovoltaic applications.
Leng S; Wex B; Chan LH; Graham MJ; Jin S; Jing AJ; Jeong KU; Van Horn RM; Sun B; Zhu M; Kaafarani BR; Cheng SZ
J Phys Chem B; 2009 Apr; 113(16):5403-11. PubMed ID: 19368409
[TBL] [Abstract][Full Text] [Related]
15. Milk fat thermal properties and solid fat content in emmental cheese: a differential scanning calorimetry study.
Lopez C; Briard-Bion V; Camier B; Gassi JY
J Dairy Sci; 2006 Aug; 89(8):2894-910. PubMed ID: 16840605
[TBL] [Abstract][Full Text] [Related]
16. Melt sonocrystallization of ibuprofen: effect on crystal properties.
Manish M; Harshal J; Anant P
Eur J Pharm Sci; 2005 May; 25(1):41-8. PubMed ID: 15854799
[TBL] [Abstract][Full Text] [Related]
17. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
[TBL] [Abstract][Full Text] [Related]
18. Modification of the crystal habit of celecoxib for improved processability.
Banga S; Chawla G; Varandani D; Mehta BR; Bansal AK
J Pharm Pharmacol; 2007 Jan; 59(1):29-39. PubMed ID: 17227618
[TBL] [Abstract][Full Text] [Related]
19. Size-dependent structural transformations of hematite nanoparticles. 1. Phase transition.
Chernyshova IV; Hochella MF; Madden AS
Phys Chem Chem Phys; 2007 Apr; 9(14):1736-50. PubMed ID: 17396185
[TBL] [Abstract][Full Text] [Related]
20. The effect of crystal morphology and mill type on milling induced crystal disorder.
Chikhalia V; Forbes RT; Storey RA; Ticehurst M
Eur J Pharm Sci; 2006 Jan; 27(1):19-26. PubMed ID: 16246535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
